References
1. Swerdlow S, Campo E, Harris NL, et al (eds): WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Geneva, Switzerland, World Health Organization, 2008, ed 4, pp 109-149.
2. Dash S, Sarode R, Day P, et al. An association of acute myeloid leukaemia and multiple myeloma: a case study. Indian J Cancer 1991;28:45-47.
3. Luca DC, Almanaseer IY. Simultaneous presentation of multiple myeloma and acute monocytic leukemia. Arch Pathol Lab Med 2003;127:1506-1508.
4. Attili S, Lakshmiah KC, Madhumati M. Simultaneous occurrence of multiple myeloma and acute myeloid leukaemia. Turk J Haematol 2006;23:209-211.
5. Yanagimoto M, Usuki K, Iijima K, et al. Simultaneous occurrence of acute myeloid leukemia with multilineage dysplasia and multiple myeloma [in Japanese]. Rinsho Ketsueki 2003;44:19-24.
6.Shukla J, Patne SC, Singh NK, et al. Simultaneous appearance of dual malignancies of hematopoietic system—multiple myeloma and acute myeloid leukemia. Indian J Pathol Microbiol 2008;51:118-120.
7. Kyle RA, Therneau TM, Rajkumar SV, et al. Prevalence of monoclonal gammopathy of undetermined significance. N Eng J Med 2006;354:1362-1369.
8. Landgren O, Katzmann JA, Hsing AW, et al. Prevalence of monoclonal gammopathy of undetermined significance among men in Ghana. Mayo Clin Proc 2007;82:1468-1473.
9. Iwanaga M, Tagawa M, Tsukasaki K, et al. Prevalence of monoclonal gammopathy of undetermined significance: study of 52,802 persons in Nagasaki City, Japan. Mayo Clin Proc 2007;82:1474-1479.
10. Kyle RA, Therneau TM, Rajkumar SV, et al. A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Eng J Med 2002;346:564-569.
11. Kyle RA, Therneau TM, Rajkumar SV, et al. Long-term follow-up of 241 patients with monoclonal gammopathy of undetermined significance: the original Mayo Clinic series 25 years later. Mayo Clin Proc 2004;79:859-866.
12. Bida JP, Kyle RA, Therneau TM, et al. Disease associations with monoclonal gammopathy of undetermined significance: a population-based study of 17,398 patients. Mayo Clin Proc2009;84:685-693.
13. Raz I, Polliack A. Coexistence of myelomonocytic leukemia and monoclonal gammopathy or myeloma. Simultaneous presentation in three patients. Cancer 1984;53:83-85.
14. Löwenberg B, Downing JR, Burnett A. Acute myeloid leukemia. N Eng J Med 1999;341:1051-1062.
15. Raab MS, Podar K, Breitkreutz I, et al. Multiple myeloma. Lancet 2009;374:324-339.
16. Khaled Y, Mellacheruvu S, Reddy P, et al. Long-term outcomes following myeloablative allogeneic transplantation for multiple myeloma compared to autologous transplantation and the impact of graft-versus-myeloma effect. Bone Marrow Transplant 2009;44:325-326.
17. Maloney DG, Gahrton G. Allogeneic hematopoietic cell transplantation for multiple myeloma, in Blume KG, Forman SJ, Appelbaum FR (eds): Thomas' Hematopoietic Cell Transplantation. Hoboken, NJ, Wiley-Blackwell, 2004, ed 3, pp 1096-1104.
18. Bensinger WI, Buckner CD, Anasetti C, et al. Allogeneic marrow transplantation for multiple myeloma: an analysis of risk factors on outcome. Blood 1996;88:2787-2793.
19. Gahrton G, Svensson H, Cavo M, et al. Progress in allogenic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983-93 and 1994-98 at European Group for Blood and Marrow Transplantation centres. Br J Haematol 2001;113:209-216.
20. Koreth J, Schlenk R, Kopecky K, et al. Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials. JAMA 2009;301:2349-2361.